Staphylococcus aureus, Enterococcus faecalis, Streptococcus pyogenes, Vibrio cholerae, Campylobacter, Bacteroides spp. It also has antibacterial activities against Trichomonas, Giardia lamblia at certain concentration. Its mechanism of action is by interfering with the bacterial oxidoreductase and thereby blocking the normal metabolism of bacteria. It is mainly used for treatment of various intestinal infections, dysentery, diarrhea, enteritis, Escherichia coli septicemia, typhoid, cholera, infectious rhinitis, blackhead, trichomoniasis, coccidiosis and Cartesian WBC. It can also be combined together with other drugs such as antacids for treatment of Helicobacter pylori-induced inflammation.
| Product Name: | Furazolidone |
| Synonyms: | FURAZOLIDONE BP / USP;FURAZOLIDONE BP 98;foroxone;3-(5-Nitrofurfurylideneamino)-2-oxazolidione;FURAZOLIDONE VETRANAL, 250 MG;Furazolidone,98%;FURAZOLIDONE,USP;3-(5-NITROFURFURYLIDENEAMINO)OXAZOLIDIN-2-ONE(FURAZOLIDONE) |
| CAS: | 67-45-8 |
| MF: | C8H7N3O5 |
| MW: | 225.16 |
| EINECS: | 200-653-3 |
| Product Categories: | -;Active Pharmaceutical Ingredients;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;Pharmaceutical intermediate;FUROXONE;Pharmaceutical intermediates |
| Mol File: | 67-45-8.mol |
